CG Oncology, Inc. (CGON) Institutional Ownership & Insider Trading
227 institutions reported holding CG Oncology, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 20 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CGONCG Oncology, Inc.Follow CGON — free
—
Price chart with a free account
- Market cap
- 5.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters227 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +5.3%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 227 | 94 | +5.3% | 89 | 28 | 68 | 32 |
| Mar 26 | 233 | 90 | +9.3% | 77 | 52 | 57 | 20 |
| Dec 25 | 193 | 83 | +2.6% | 68 | 33 | 49 | 16 |
| Sep 25 | 173 | 78 | +2.6% | 51 | 29 | 51 | 18 |
| Jun 25 | 161 | 76 | +7.3% | 75 | 38 | 26 | 17 |
| Mar 25 | 142 | 71 | +7.2% | 59 | 23 | 30 | 22 |
| Dec 24 | 139 | 66 | +20.9% | 56 | 27 | 26 | 15 |
| Sep 24 | 121 | 52 | +17.4% | 59 | 22 | 19 | 15 |
CG Oncology, Inc. — questions
- Who owns CG Oncology, Inc. stock?
- 227 institutions reported CG Oncology, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: RTW INVESTMENTS, LP (9.6%), T. Rowe Price Investment Management, Inc. (7.5%), Decheng Capital LLC (7.2%).
- Are CG Oncology, Inc. insiders buying or selling?
- 20 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from CG Oncology, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.